Please assess the completion status of the following clinical trial:

Trial Title: BlueSync Field Evaluation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient will be/has been implanted with an Azure™ or Percepta™, Serena™, Solara™ CRT-P device compatible with BlueSync™ (both new and replacement devices are allowed)~* Patient must own a smart device (Smartphone or tablet) that meets system requirements and be willing to use during evaluation period~* Patient must be able to complete the required 12-month follow-up after enrollment~* Patients must be of legal age according to local law~Exclusion Criteria:~* Patient unwilling to complete required surveys during 12-month evaluation period

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Evaluation Group (Type: None): Patients implanted with a pacemaker or CRT-P device who will be using remote monitoring via the MyCareLink Heart App
- Control Group (Type: None): Patients with low power implantable devices and CareLink Monitor 2490 (Excluding wireless model 2490C)

Based on this trial design, predict the completion outcome and termination type (if applicable).